Vol. 28.Issue. 2. March - April 2023 | Annals of Hepatology

¿Aún no está registrado?

Información relevante

Consulte los artículos y contenidos publicados en éste medio, además de los e-sumarios de las revistas científicas en el mismo momento de publicación

Máxima actualización

Esté informado en todo momento gracias a las alertas y novedades

Promociones exclusivas

Acceda a promociones exclusivas en suscripciones, lanzamientos y cursos acreditados

Crear Mi cuenta

* = Required fields

Enter your email address

User name *

Annals of Hepatology

Buscar en

Annals of Hepatology

Toda la web

Inicio Annals of Hepatology

ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option

Indexed in:

Scopus, Web of Science, Medline/PubMed, DOAJ and Conacyt

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2022

3.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2022

6.3

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2022

0.859

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more

SNIP 2022

0.989

View more metrics

Journal Information

Previous Issue | Next Issue

Issue

Vol. 28. Issue 2.

(March - April 2023)

Editorial board

Ann Hepatol. 2023;28:101091

Full text access

Editorial

Immunotherapy for HCC: limitations in patients with NASH

Parul D. Agarwal, Michael R. Lucey, Adnan Said, Jeremy Kratz

Ann Hepatol. 2023;28:100886

Full text access

Opinions

Targeting cellular senescence as a therapeutic approach in non-alcoholic steatohepatitis

Yasuhiro Nakano, Yoshikazu Johmura

Ann Hepatol. 2023;28:100900

Full text access

Concise reviews

Clinical application of Magnetic resonance elastography in hepatocellular carcinoma: from diagnosis to prognosis

Jiaxu Liang, Javier Ampuero, Javier Castell, Qiong Zhang, Sijia Zhang, Yong Chen, Manuel Romero-Gómez

Ann Hepatol. 2023;28:100889

Full text access

Original articles

Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network

Marina Farah, Chimaobi Anugwom, Javier Diaz Ferrer, Estefania Liza Baca, Angelo Z. Mattos, João Pedro P. Possebon, Marco Arrese, Jhon Prieto, ... Jose D. Debes

Ann Hepatol. 2023;28:100876

Full text access

Comparison of surgical resection and transcatheter arterial chemoembolization for large hepatocellular carcinoma: a systematic review and meta-analysis

Luke Zhou, Mao Zhang, Siyu Chen

Ann Hepatol. 2023;28:100890

Full text access

Genomic landscape of Chinese patients with hepatocellular carcinoma using next-generation sequencing and its association with the prognosis

Zhao Yang, Jianwei Liu, Feng Xue, Lei Zhang, Hui Xue, Yeye Wu, Shilei Bai, Furong Du, ... Kui Wang

Ann Hepatol. 2023;28:100898

Full text access

Daytime napping and risk of liver cancer: A large population-based prospective cohort study

Ahmed Arafa, Ehab S. Eshak, Kokoro Shirai, Isao Muraki, Akiko Tamakoshi, Hiroyasu Iso

Ann Hepatol. 2023;28:100877

Full text access

High prevalence of periodontal disease in patients with NASH- possible association of poor dental health with NASH severity

Sven Pischke, Anita Shiprov, Ulrike Peters, Julian Schulze zur Wiesch, Johannes Kluwe, Tim Westphal, Frank Fischer, Maria Mader, ... Thomas Beikler

Ann Hepatol. 2023;28:100887

Full text access

Blood pressure stratification for predicting liver fibrosis risk in metabolic dysfunction associated fatty liver disease

Jing Liu, Haifeng Lv, Jie Wang, Qianru Zhu, Gongying Chen, Yanming Jiang, Ke Zhao, Li Shao, ... Xiaoben Pan

Ann Hepatol. 2023;28:100892

Full text access

Validation of the Hepamet fibrosis score in a multi-ethnic Asian population

Shi-En Chong, Felicia Chang, Kee-Huat Chuah, Pavai Sthaneshwar, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Wah-Kheong Chan

Ann Hepatol. 2023;28:100888

Full text access

Hepatitis E virus superinfection impairs long-term outcome in hospitalized patients with hepatitis B virus-related decompensated liver cirrhosis

Hong Zhao, Wenyi Ye, Xia Yu, Jianhua Hu, Xuan Zhang, Meifang Yang, Jifang Sheng, Yu Shi

Ann Hepatol. 2023;28:100878

Full text access

Effectiveness of elbasvir/grazoprevir plus ribavirin for hepatitis C virus genotype 1a infection and baseline NS5A resistance

Deanna D. Hill, Jennifer R. Kramer, Kassie R. Chaffin, T. Christopher Mast, Michael N. Robertson, Fasiha Kanwal, Barbara A. Haber

Ann Hepatol. 2023;28:100899

Full text access

Impaired anti-HBV vaccine response in non-cirrhotic chronic HCV is not overcome by double dose regimen: randomized control trial

Roseane P. Medeiros, Norah A. Terrault, Daniel F. Mazo, Claudia P. Oliveira, Jennifer Dodge, Patricia M. Zitelli, Marta H. Lopes, Flair J. Carrilho, Mário G. Pessoa

Ann Hepatol. 2023;28:100891

Full text access

Letters to the editor

On the risk of further excluding outcast patient populations in South America

Eloy Ruiz, Ramiro Fernández, Francisco Berrospi, Sandro Casavilca-Zambrano, Juan Contreras-Mancilla, Juan Pablo Cerapio, Pascal Pineau, Stéphane Bertani

Ann Hepatol. 2023;28:100901

Full text access

Response to “On the risk of further excluding outcast patient populations in South America”

Jose D. Debes, Chimaobi Anugwom, Marina Farah, Javier Diaz-Ferrer

Ann Hepatol. 2023;28:100903

Full text access

Hepatocellular carcinoma in Colombia 2017 – 2021

Andres Gomez-Aldana, Diego Rosselli

Ann Hepatol. 2023;28:100902

Full text access